Serotypes and Antimicrobial Susceptibility of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children Less Than 5 Years Old in Egypt

References

• Ludwig E, Bonanni P, Rohde G, Sayiner A, Torres A. The remaining challenges of pneumococcal disease in adults. Eur Respir Rev. 2012;21(123):57–65. doi:doi:10.1183/09059180.0000891122379175
   PubMedGoogle Scholar
• Tricarico S, McNeil HC, Cleary DW, et al. Pneumococcal conjugate vaccine implementation in middle-income countries. Pneumonia. 2017;9(1). doi:doi:10.1186/s41479-017-0030-5
   Google Scholar
• Badawy M, El Kholy A, Sherif MM, et al. Serotypes of Streptococcus pneumoniae in Egyptian children: are they covered by pneumococcal conjugate vaccines? Eur J Clin Microbiol Infect Dis. 2017;36(12):2385–2389. doi:doi:10.1007/s10096-017-3071-z28744663
   PubMed Web of Science ®Google Scholar
• Straume D, Stamsås GA, Håvarstein LS. Natural transformation and genome evolution in Streptococcus pneumoniae. Infect Genet Evol. 2015;33:371–380. doi:doi:10.1016/j.meegid.2014.10.02025445643
   PubMed Web of Science ®Google Scholar
• Satzke C, Turner P, Virolainen-Julkunen A, et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine. 2013;32(1):165–179. doi:doi:10.1016/j.vaccine.2013.08.06224331112
   PubMed Web of Science ®Google Scholar
• Croisier-Bertin D, Piroth L, Charles P-E, et al. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing. Antimicrob Agents Chemother. 2011;55(7):3557–3563. doi:doi:10.1128/AAC.01773-0921576444
   PubMed Web of Science ®Google Scholar
• CLSI. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second Informational Supplement Clinical and Laboratory Standards Institute; 2015.
   Google Scholar
• CDC, Ncird. Protocol for Multiplex PCR-S. pneumoniae SEROTYPING - clinical specimens and pneumococcal isolates - African set. 2010. doi:10.1128/JCM.02243-09
   Google Scholar
• Carvalho MDG, Pimenta FC, Jackson D, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. 2010;48(5):1611–1618. doi:doi:10.1128/JCM.02243-0920220175
   PubMed Web of Science ®Google Scholar
• CDC, Ncird. Real-time PCR targets for Streptococcus species detection and antibiotic susceptibility in SPN*. doi:10.1371/journal.pone.0032169
   Google Scholar
• Srinivasan V, Du Plessis M, Beall BW, McGee L. Quadriplex real-time polymerase chain reaction (lytA, mef, erm, pbp2bwt) for pneumococcal detection and assessment of antibiotic susceptibility. Diagn Microbiol Infect Dis. 2011;71(4):453–456. doi:10.1016/j.diagmicrobio.2011.08.01721996097
   PubMed Web of Science ®Google Scholar
• Wasfy MO, Pimentel G, Abdel-Maksoud M, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae causing meningitis in Egypt, 1998-2003. J Antimicrob Chemother. 2005;55(6):958–964. doi:10.1093/jac/dki10115820983
   PubMed Web of Science ®Google Scholar
• Shibl A, Memish Z, Pelton S. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt. Int J Antimicrob Agents. 2009;33(5):410.e1-410.e9. doi:10.1016/j.ijantimicag.2008.08.012
   Web of Science ®Google Scholar
• Assefa A, Gelaw B, Shiferaw Y, Tigabu Z. Nasopharyngeal carriage and antimicrobial susceptibility pattern of streptococcus pneumoniae among pediatric outpatients at gondar university hospital, north west ethiopia. Pediatr Neonatol. 2013;54(5):315–321. doi:10.1016/j.pedneo.2013.03.01723680262
   PubMed Web of Science ®Google Scholar
• Salvadori G, Junges R, Morrison DA, Petersen FC. Competence in streptococcus pneumoniae and close commensal relatives: mechanisms and implications. Front Cell Infect Microbiol. 2019. doi:10.3389/fcimb.2019.00094
   Web of Science ®Google Scholar
• Draz IH, Halawa EF, Wahby G, Ismail DK, Meligy BS. Pneumococcal infection among hospitalized Egyptian children. J Egypt Public Health Assoc. 2015;90(2):52–57. doi:10.1097/01.EPX.0000465234.31794.b126154831
   PubMedGoogle Scholar
• Sabry NA, Farid SF, Dawoud DM. Antibiotic dispensing in Egyptian community pharmacies: an observational study. Res Soc Adm Pharm. 2014;10(1):168–184. doi:10.1016/j.sapharm.2013.03.004
   PubMed Web of Science ®Google Scholar
• El-Hawy RM, Ashmawy MI, Kamal MM, et al. Studying the knowledge, attitude and practice of antibiotic misuse among Alexandria population. Eur J Hosp Pharm. 2017;24(6):349–354. doi:10.1136/ejhpharm-2016-00103231156970
   PubMedGoogle Scholar
• Aly SA, Elsherbiny NM, Ahmed SH, El-asheer OM. Prevalence of Streptococcus pneumoniae in Egyptian children. 2017;3(8):103–107.
   Google Scholar
• Manoharan A, Manchanda V, Balasubramanian S, et al. Invasive pneumococcal disease in children aged younger than 5 years in India: a surveillance study. Lancet Infect Dis. 2017;17(3):305–312. doi:10.1016/S1473-3099(16)30466-227956163
   PubMed Web of Science ®Google Scholar
• Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355–367. doi:10.1038/s41579-018-0001-829599457
   PubMed Web of Science ®Google Scholar
• Balsells E, Dagan R, Yildirim I, et al. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: a systematic review and meta-analysis. J Infect. 2018;77(5):368–378. doi:10.1016/j.jinf.2018.06.00429964140
   PubMed Web of Science ®Google Scholar
• Yildirim I, Hanage WP, Lipsitch M, et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine. 2010;29(2):283–288. doi:10.1016/j.vaccine.2010.10.03221029807
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000. doi:10.1086/313608
   Web of Science ®Google Scholar
• Talaat M, Saied T, Kandeel A, et al. A point prevalence survey of antibiotic use in 18 hospitals in Egypt. Antibiotics. 2014;3(3):450–460. doi:10.3390/antibiotics303045027025755
   PubMedGoogle Scholar
• See I, Lessa FC, ElAta OA, et al. Incidence and pathogen distribution of healthcare-associated infections in pilot Hospitals in Egypt. Infect Control Hosp Epidemiol. 2013;34(12):1281–1288. doi:10.1086/67398524225613
   PubMed Web of Science ®Google Scholar
• Stacevičiene I, Petraitiene S, Vaičiuniene D, Alasevičius T, Kirsliene J, Usonis V. Antibiotic resistance of Streptococcus pneumoniae, isolated from nasopharynx of preschool children with acute respiratory tract infection in Lithuania. BMC Infect Dis. 2016;16(1). doi:10.1186/s12879-016-1544-9
   Web of Science ®Google Scholar
• Vanderkooi OG, McConnell A, Church DL, Kellner JD. Antimicrobial susceptibility of invasive and lower respiratory tract isolates of Streptococcus pneumoniae, 1998 to 2007. Can J Infect Dis Med Microbiol. 2009;20(4):139–144. doi:10.1155/2009/413749
   Google Scholar
• Powis J, McGeer A, Green K, et al. In vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002. Antimicrob Agents Chemother. 2004;48(9):3305–3311. doi:10.1128/AAC.48.9.3305-3311.200415328089
   PubMed Web of Science ®Google Scholar
• Weiss K, et al. Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin. J Antimicrob Chemother. 2002;50(3):403–406. doi:10.1093/jac/dkf14612205066
   PubMed Web of Science ®Google Scholar
• Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF. Factors associated with relative rates of antimicrobial resistance among streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998–2002). Clin Infect Dis. 2003;36(8):963–970. doi:10.1086/37405212684907
   PubMed Web of Science ®Google Scholar
• Nagai K. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J Antimicrob Chemother. 2001;48(6):915–918. doi:10.1093/jac/48.6.91511733479
   PubMed Web of Science ®Google Scholar
• Diawara I, Nayme K, Katfy K, et al. Analysis of amino acid motif of penicillin-binding proteins 1a, 2b, and 2x in invasive Streptococcus pneumoniae nonsusceptible to penicillin isolated from pediatric patients in Casablanca, Morocco. BMC Res Notes. 2018;11(1). doi:10.1186/s13104-018-3719-5
   Google Scholar
• Fukushima KY, Yanagihara K, Hirakata Y, et al. Rapid identification of penicillin and macrolide resistance genes and simultaneous quantification of Streptococcus pneumoniae in purulent sputum samples by use of a novel real-time multiplex PCR assay. J Clin Microbiol. 2008;46(7):2384–2388. doi:10.1128/JCM.00051-0818463207
   PubMed Web of Science ®Google Scholar
• Tait-Kamradt A, Davies T, Cronan M, Jacobs MR, Appelbaum PC, Sutcliffe J. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob Agents Chemother. 2000;44(8):2118–2125. doi:10.1128/AAC.44.8.2118-2125.200010898684
   PubMed Web of Science ®Google Scholar